1 / 14

Proteinuria as a Surrogate Outcome in Chronic Kidney Disease

Proteinuria as a Surrogate Outcome in Chronic Kidney Disease. Early Diabetes – Microalbuminuria (MA) Type 2 Diabetes in American Indians Robert G Nelson, MD, PhD NIDDK, Phoenix. Population. Pima Indians from the Gila River Indian Community in Arizona

avian
Download Presentation

Proteinuria as a Surrogate Outcome in Chronic Kidney Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Proteinuria as a Surrogate Outcome in Chronic Kidney Disease Early Diabetes – Microalbuminuria (MA) Type 2 Diabetes in American Indians Robert G Nelson, MD, PhD NIDDK, Phoenix

  2. Population • Pima Indians from the Gila River Indian Community in Arizona • Biennial examinations since 1965 of all community members ≥5 years old • Medical history/physical examination • Height, weight, blood pressure • Blood and urine tests • Retinal examinations and photographs • ECG • Oral Glucose Tolerance Test • Registries • ESRD • Mortality

  3. Definitions Measure of Albuminuria Collection: Daytime untimed “spot” urine specimens Analyte: Urinary Albumin to Creatinine Ratio (ACR; in mg/g) Analytical methods: Albumin – immunonephelometry (Dade Behring, Inc.); Creatinine – modified Jaffe reaction (Envoy 500) Thresholds: <30 mg/g; normoalbuminuria (NA) 30-299 mg/g; microalbuminuria (MA) ≥300 mg/g; macroalbuminuria Measure of Proteinuria Collection: Daytime untimed “spot” urine specimens Analyte: Urinary Protein to Creatinine Ratio (PCR; in g/g) Analytical methods: Protein – Shevky-Stafford; Creatinine – modified Jaffe reaction (Envoy 500) Thresholds: ≥0.5 g/g (or ≥1.0 g/g in some studies)

  4. Age-Sex-Adjusted Death Ratesin Pima Indians ≥45 Years Old Age-sex-duration adjusted death rate ratio 3.5 (95% CI, 2.8-4.4) Diabetes 37:1499-1504, 1988

  5. Prevalence of Elevated Albuminuria Diabetologia 32:870-876, 1989

  6. Incidence of Proteinuria by Level of Albuminuria Figure.Age-sex-adjusted incidence of proteinuria in diabetic Pima Indians by albuminuria category. Arch Intern Med 151:1761-1765, 1991

  7. Age-Sex-Adjusted Incidence of SCr ≥2.0 mg/dl by Duration of Diabetes and Presence of Proteinuria Age-sex-duration adjusted incidence rate ratio 42 (95% CI, 24-75) Kidney Int 35:681-687, 1989

  8. Cumulative Incidence of ESRDby Duration of Proteinuria 80 Whites with type 1 Pimas with type 2 60 Percent 40 20 0 0 5 10 15 Duration of Proteinuria (years) Diabetologia 36:1087-1093, 1993

  9. Mean (±SE) Change in GFRAccording to Albuminuria at Baseline N Engl J Med 335:1636-1642, 1996

  10. Sequential Measures of Albuminuria Am J Kidney Dis 51:759-766, 2008

  11. Changes in ACR Categories Between Two ACR Measurements Taken Within a 6-year Period Am J Kidney Dis 51:759-766, 2008

  12. Incidence Rate Ratio for Diabetic ESRD (N=89 cases) Relative to Persistently Normal ACR Am J Kidney Dis 51:759-766, 2008

  13. Incidence of Diabetic ESRD Kidney Int 70:1840-1846, 2006

  14. Summary • MA occurs frequently in type 2 diabetes • MA predicts development of overt nephropathy • MA frequently regresses to normoalbuminuria • Low current ACR is associated with a good prognosis regardless of earlier values • Proteinuria strongly predicts progression to renal insufficiency, ESRD, and death • Distribution of albuminuria is changing over time

More Related